SK-216
CAS: 654080-03-2
Ref. 3D-EBB08003
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Información del producto
SK-216 is a drug that inhibits the synthesis of messenger RNA and suppresses angiogenesis. This drug has been shown to reduce the number of blood vessels in lung fibroblasts and subcutaneous tumors in mice, as well as inhibit the proliferation of cancer cells. SK-216 also stimulates lipoprotein lipase activity in wild-type mice and blocks angiogenesis by inhibiting the production of angiogenic factors such as VEGF and TGF-β1. SK-216 is currently being studied for its potential use in the treatment of pleural mesothelioma, urokinase-type plasminogen activator (uPA) receptor positive epithelial mesenchymal cells.
Propiedades químicas
Consulta técnica sobre: 3D-EBB08003 SK-216
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
